Treatment of childhood hypercholesterolemia with HMG-CoA reductase inhibitors

Annals of Pharmacotherapy

Volumn 33, Issue 11, 1999, Pages 1224-1227

  Duplaga, Beth A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Adolescence; Childhood; HMG CoA reductase inhibitors; Hypercholesterolemia; Hyperlipidemia

Indexed keywords

AMINOTRANSFERASE; CHOLESTEROL; CREATINE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; SIMVASTATIN;

ADOLESCENT; ARTICLE; CHILD; CORONARY ARTERY DISEASE; DIET THERAPY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERCHOLESTEROLEMIA; INFANT; JAUNDICE; LYMPHADENITIS; MAJOR CLINICAL STUDY; MALE; MYALGIA; PRIORITY JOURNAL; THORAX PAIN;

ADOLESCENT; ANTICHOLESTEREMIC AGENTS; CHILD; CLINICAL TRIALS; CORONARY DISEASE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; INFANT; INFANT, NEWBORN; MALE;

EID: 0032721208     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.19078     Document Type: Article

References (17)

1. Kwiterovich PO. Pediatric implications of heterozygous familial hypercholesterolemia. Screening and dietary treatment. Arteriosclerosis 1989; 9(suppl I):111I-20I.
2. Moll PP, Sing CF, Weidman WH, Gordon H, Ellefson RD, Hodgson PA, et al. Total cholesterol and lipoproteins in school children: prediction of coronary heart disease in adult relatives. Circulation 1983;67:127-34.
3. Berenson GS, Srinivasan SR, Bao W, Newman WP III, Tracy RE, Wattingney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med 1998; 338:1650-6.
4. Strong JP, Malcom GT, McMahan CA, Tracy RE, Newman WP III, Herderick EE, et al. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA 1999; 281:727-35.
5. Rifkind BM, Schucker B, Gordon DJ. When should patients with heterozygous familial hypercholesterolemia be treated (editorial)? JAMA 1999;281:180-1.
6. Lauer RM, Clarke WR. Use of cholesterol measurements in childhood for the prediction of adult hypercholesterolemia. The Muscatine Study. JAMA 1990;264:3034-8.
7. Winkleby MA, Robinson TN, Sundquist J, Kraemer HC. Ethnic variation in cardiovascular disease risk factors among children and young adults: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. JAMA 1999;281:1006-13.
8. National Cholesterol Educational Program. Report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992;89: 525-84.
9. American Academy of Pediatrics Committee on Nutrition. Cholesterol in childhood. Pediatrics 1998;101:141-7.
10. Lambert M, Lupien PJ, Gagne C, Levy E, Blaichman S, Langlois S, et al. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Pediatrics 1996;97:619-28.
11. Newman TB, Browner WS, Hulley SB. The case against childhood cholesterol screening. JAMA 1990;264:3039-43.
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 1993;269:3015-23.
13. Stein EA. Treatment of familial hypercholesterolemia with drugs in children. Arteriosclerosis 1989;9(suppl I):145I-51I.
14. Ducobu J, Brasseur D, Chaudron JM, Deslypere JP, Harvengt C, Muls E, et al. Simvastatin use in children (letter). Lancet 1992;339:1388.
15. Sinzinger H, Schmid P, Pirich C, Virgolini I, Pesau B, Granegger S, et al. Treatment of hypercholesterolaemia in children (letter). Lancet 1992; 340:548-9.
16. Knipscheer HC, Boelen CC, Kastelein JJ, van Diermen DE, Groenemeijer BE, van den Ende A, et al. Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia. Pediatr Res 1996;39:867-71.
17. Stein EA, Illingworth DR, Kwiterovich PO, Liacouras CA, Siimes MA, Jacobson MS, et al. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia. A randomized controlled trial. JAMA 1999;281:137-44.